BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11681710)

  • 1. In vivo effects of vanadium in diabetic rats are independent of changes in PI-3 kinase activity in skeletal muscle.
    Mohammad A; Bhanot S; McNeill JH
    Mol Cell Biochem; 2001 Jul; 223(1-2):103-8. PubMed ID: 11681710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo effects of insulin and bis(maltolato)oxovanadium (IV) on PKB activity in the skeletal muscle and liver of diabetic rats.
    Marzban L; Bhanot S; McNeill JH
    Mol Cell Biochem; 2001 Jul; 223(1-2):147-57. PubMed ID: 11681716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bis(maltolato) oxovanadium (IV) on protein serine kinases in skeletal muscle of streptozotocin-diabetic rats.
    Bhanot S; Girn J; Poucheret P; McNeill JH
    Mol Cell Biochem; 1999 Dec; 202(1-2):131-40. PubMed ID: 10706003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nonspecific phosphotyrosine phosphatase inhibitor, bis(maltolato)oxovanadium(IV), improves glucose tolerance and prevents diabetes in Zucker diabetic fatty rats.
    Winter CL; Lange JS; Davis MG; Gerwe GS; Downs TR; Peters KG; Kasibhatla B
    Exp Biol Med (Maywood); 2005 Mar; 230(3):207-16. PubMed ID: 15734724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the glucose-lowering properties of vanadyl sulfate and bis(maltolato)oxovanadium(IV) following acute and chronic administration.
    Yuen VG; Orvig C; McNeill JH
    Can J Physiol Pharmacol; 1995 Jan; 73(1):55-64. PubMed ID: 7600453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bis(maltolato)oxovanadium(IV) inhibits the activity of PTP1B in Zucker rat skeletal muscle in vivo.
    Mohammad A; Wang J; McNeill JH
    Mol Cell Biochem; 2002 Jan; 229(1-2):125-8. PubMed ID: 11936837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-lowering effects of a new organic vanadium complex, bis(maltolato)oxovanadium(IV).
    Yuen VG; Orvig C; McNeill JH
    Can J Physiol Pharmacol; 1993; 71(3-4):263-9. PubMed ID: 8402390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and chronic oral administration of bis(maltolato)oxovanadium(IV) in Zucker diabetic fatty (ZDF) rats.
    Yuen VG; Vera E; Battell ML; Li WM; McNeill JH
    Diabetes Res Clin Pract; 1999 Jan; 43(1):9-19. PubMed ID: 10199584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms by which bis(maltolato)oxovanadium(IV) normalizes phosphoenolpyruvate carboxykinase and glucose-6-phosphatase expression in streptozotocin-diabetic rats in vivo.
    Marzban L; Rahimian R; Brownsey RW; McNeill JH
    Endocrinology; 2002 Dec; 143(12):4636-45. PubMed ID: 12446591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of bis(maltolato)oxovanadium(IV) are distinct from food restriction in STZ-diabetic rats.
    Yuen VG; Orvig C; McNeill JH
    Am J Physiol; 1997 Jan; 272(1 Pt 1):E30-5. PubMed ID: 9038848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of vanadium on insulin sensitivity and appetite.
    Wang J; Yuen VG; McNeill JH
    Metabolism; 2001 Jun; 50(6):667-73. PubMed ID: 11398143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vanadium increases GLUT4 in diabetic rat skeletal muscle.
    Mohammad A; Sharma V; McNeill JH
    Mol Cell Biochem; 2002 Apr; 233(1-2):139-43. PubMed ID: 12083368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in cardiac dysfunction in streptozotocin-induced diabetic rats following chronic oral administration of bis(maltolato)oxovanadium(IV).
    Yuen VG; Orvig C; Thompson KH; McNeill JH
    Can J Physiol Pharmacol; 1993; 71(3-4):270-6. PubMed ID: 8402391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo effects of vanadium on GLUT4 translocation in cardiac tissue of STZ-diabetic rats.
    Li SH; McNeill JH
    Mol Cell Biochem; 2001 Jan; 217(1-2):121-9. PubMed ID: 11269655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of chronic treatment with Bis(maltolato)oxovanadium (IV) in rat model of non-insulin-dependent-diabetes.
    Shinde UA; Mehta AA; Goyal RK
    Indian J Exp Biol; 2001 Sep; 39(9):864-70. PubMed ID: 11831366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skeletal muscle mitogen-activated protein kinases and ribosomal S6 kinases. Suppression in chronic diabetic rats and reversal by vanadium.
    Hei YJ; Chen X; Pelech SL; Diamond J; McNeill JH
    Diabetes; 1995 Oct; 44(10):1147-55. PubMed ID: 7556949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
    Wasan KM; Risovic V; Yuen VG; McNeill JH
    J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in iron metabolism and oxidative status in STZ-induced diabetic rats treated with bis(maltolato) oxovanadium (IV) as an antidiabetic agent.
    Sánchez-González C; López-Chaves C; Trenzado CE; Aranda P; López-Jurado M; Gómez-Aracena J; Montes-Bayón M; Sanz-Medel A; Llopis J
    ScientificWorldJournal; 2014; 2014():706074. PubMed ID: 24511298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of in vivo effect of vanadium on GLUT4 translocation in white adipose tissue of streptozotocin-diabetic rats.
    Cam MC; Brownsey RW; Rodrigues B; McNeill JH
    Metabolism; 2001 Jun; 50(6):674-80. PubMed ID: 11398144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bis(maltolato)oxovanadium(IV) (BMOV) Attenuates Apoptosis in High Glucose-Treated Cardiac Cells and Diabetic Rat Hearts by Regulating the Unfolded Protein Responses (UPRs).
    Cong XQ; Piao MH; Li Y; Xie L; Liu Y
    Biol Trace Elem Res; 2016 Oct; 173(2):390-8. PubMed ID: 26983714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.